BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 9219725)

  • 1. Cathepsin B and cysteine proteinase inhibitors in human lung cancer cell lines.
    Heidtmann HH; Salge U; Abrahamson M; Bencina M; Kastelic L; Kopitar-Jerala N; Turk V; Lah TT
    Clin Exp Metastasis; 1997 Jul; 15(4):368-81. PubMed ID: 9219725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer.
    Krepela E; Procházka J; Kárová B; Cermák J; Roubková H
    Neoplasma; 1998; 45(5):318-31. PubMed ID: 9921922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystatins and stefins in ascites fluid from ovarian carcinoma.
    Lah TT; Kokalj-Kunovar M; Kastelic L; Babnik J; Stolfa A; Rainer S; Turk V
    Cancer Lett; 1992 Jan; 61(3):243-53. PubMed ID: 1739949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cathepsin B activity in human lung tumor cell lines: ultrastructural localization, pH sensitivity, and inhibitor status at the cellular level.
    Spiess E; Brüning A; Gack S; Ulbricht B; Spring H; Trefz G; Ebert W
    J Histochem Cytochem; 1994 Jul; 42(7):917-29. PubMed ID: 8014475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential localization of cysteine protease inhibitors and a target cysteine protease, cathepsin B, by immuno-confocal microscopy.
    Calkins CC; Sameni M; Koblinski J; Sloane BF; Moin K
    J Histochem Cytochem; 1998 Jun; 46(6):745-51. PubMed ID: 9603786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretion of a latent, acid activatable cathepsin L precursor by human non-small cell lung cancer cell lines.
    Heidtmann HH; Salge U; Havemann K; Kirschke H; Wiederanders B
    Oncol Res; 1993; 5(10-11):441-51. PubMed ID: 8054705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stefin B, the major low molecular weight inhibitor in ovarian carcinoma.
    Kastelic L; Turk B; Kopitar-Jerala N; Stolfa A; Rainer S; Turk V; Lah TT
    Cancer Lett; 1994 Jul; 82(1):81-8. PubMed ID: 8033073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cysteine protease inhibitors stefin A, stefin B, and cystatin C in human lung tumor tissue.
    Ebert E; Werle B; Jülke B; Kopitar-Jerala N; Kos J; Lah T; Abrahamson M; Spiess E; Ebert W
    Adv Exp Med Biol; 1997; 421():259-65. PubMed ID: 9330706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cysteine proteinases and their protein inhibitors stefins, cystatins and kininogens.
    Turk V; Brzin J; Kotnik M; Lenarcic B; Popović T; Ritonja A; Trstenjak M; Begić-Odobasić L; Machleidt W
    Biomed Biochim Acta; 1986; 45(11-12):1375-84. PubMed ID: 3495261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystatins and cathepsins in breast carcinoma.
    Lah TT; Kokalj-Kunovar M; Drobnic-Kosorok M; Babnik J; Golouh R; Vrhovec I; Turk V
    Biol Chem Hoppe Seyler; 1992 Jul; 373(7):595-604. PubMed ID: 1515089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bovine stefin C, a new member of the stefin family.
    Turk B; Krizaj I; Kralj B; Dolenc I; Popovic T; Bieth JG; Turk V
    J Biol Chem; 1993 Apr; 268(10):7323-9. PubMed ID: 8463267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grafting of features of cystatins C or B into the N-terminal region or second binding loop of cystatin A (stefin A) substantially enhances inhibition of cysteine proteinases.
    Pavlova A; Björk I
    Biochemistry; 2003 Sep; 42(38):11326-33. PubMed ID: 14503883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in specificity for the interactions of stefins A, B and D with cysteine proteinases.
    Lenarcic B; Krizaj I; Zunec P; Turk V
    FEBS Lett; 1996 Oct; 395(2-3):113-8. PubMed ID: 8898076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory properties of low molecular mass cysteine proteinase inhibitors from human sarcoma.
    Lah TT; Clifford JL; Helmer KM; Day NA; Moin K; Honn KV; Crissman JD; Sloane BF
    Biochim Biophys Acta; 1989 Oct; 993(1):63-73. PubMed ID: 2804124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of single-domain cystatin-like cysteine proteinase inhibitors expressed by the trematode Fasciola hepatica.
    Cancela M; Corvo I; DA Silva E; Teichmann A; Roche L; Díaz A; Tort JF; Ferreira HB; Zaha A
    Parasitology; 2017 Nov; 144(13):1695-1707. PubMed ID: 28697819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the single cysteine residue, Cys 3, of human and bovine cystatin B (stefin B) in the inhibition of cysteine proteinases.
    Pol E; Björk I
    Protein Sci; 2001 Sep; 10(9):1729-38. PubMed ID: 11514663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cysteine proteinases cathepsins B and K and of cysteine proteinase inhibitor cystatin C in giant cell tumor of tendon sheath.
    Hansen T; Petrow PK; Gaumann A; Keyszer GM; Otto M; Kirkpatrick CJ; Kriegsmann J
    Mod Pathol; 2001 Apr; 14(4):318-24. PubMed ID: 11301348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Gly-4 of human cystatin A (stefin A) in the binding of target proteinases. Characterization by kinetic and equilibrium methods of the interactions of cystatin A Gly-4 mutants with papain, cathepsin B, and cathepsin L.
    Estrada S; Nycander M; Hill NJ; Craven CJ; Waltho JP; Björk I
    Biochemistry; 1998 May; 37(20):7551-60. PubMed ID: 9585570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological and prognostic role of acid cysteine proteinase inhibitor (ACPI, cystatin A) in non-small-cell lung cancer.
    Leinonen T; Pirinen R; Böhm J; Johansson R; Rinne A; Weber E; Kosma VM
    J Clin Pathol; 2007 May; 60(5):515-9. PubMed ID: 16790691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stefins and lysosomal cathepsins B, L and D in human breast carcinoma.
    Lah TT; Kokalj-Kunovar M; Strukelj B; Pungercar J; Barlic-Maganja D; Drobnic-Kosorok M; Kastelic L; Babnik J; Golouh R; Turk V
    Int J Cancer; 1992 Jan; 50(1):36-44. PubMed ID: 1728611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.